Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ashby

Showing results (81-90 of 320) with videos related to

Pageof 32
Sort By:
European Journal of Pharmacology|April 18, 1997
Examination of the effect of the cannabinoid receptor agonist, CP 55,940, on electrically evoked transmitter release from rat brain slicesA N Gifford, L Samiian, S J Gatley, et al.
Brain Research|July 24, 1989
One year treatment with haloperidol or clozapine fails to alter neostriatal D1- and D2-dopamine receptor sensitivity in the ratC R Ashby, R Hitzemann, J E Rubinstein, et al.
Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition Et Metabolisme|March 13, 2024
Interval training and cardiometabolic health in reproductive-aged femalesT Moholdt, M A J Sujan, E R Ashby, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|October 7, 2022
Handgrip Strength Index: A Novel Parameter Which Quantifies Clinical Weakness in People on HaemodialysisTina Dilloway, Damien R Ashby, Mary Hickson, et al.
Synapse (New York, N.Y.)|January 1, 1996
The effect of the acute and chronic administration of CP 96,345, a selective neurokinin1 receptor antagonist, on midbrain dopamine neurons in the rat: a single unit, extracellular recording studyY Minabe, K Emori, A Toor, et al.
Brain Research|September 9, 1996
5-HT3-like receptors in the rat medial prefrontal cortex: further pharmacological characterizationE Edwards, E Hampton, C R Ashby, et al.
Synapse (New York, N.Y.)|September 5, 2002
Effect of SA4503 on the electrically evoked release of (3)H-acetylcholine from striatal and hippocampal rat brain slicesBryan Horan, Andrew N Gifford, Kiyoshi Matsuno, et al.
Brain Research|April 9, 1990
The effect of intraventricular administration of the 5-HT3 receptor agonist 2-methylserotonin on the release of dopamine in the nucleus accumbens: an in vivo chronocoulometric studyL H Jiang, C R Ashby, R J Kasser, et al.
Synapse (New York, N.Y.)|April 9, 2015
The selective dopamine D₃ receptor antagonist SB-277011A attenuates drug- or food-deprivation reactivation of expression of conditioned place preference for cocaine in male Sprague-Dawley ratsCharles R Ashby, Onarae V Rice, Christian A Heidbreder, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1994
The behavioral effects of the stereoisomers of 4-methylaminorex, a psychostimulant, in the ratK Batsche, C R Ashby, C Lee, et al.
Pageof 32

Showing results (81-90 of 320) with videos related to

Sort By:
Pageof 32
European Journal of Pharmacology|April 18, 1997
Examination of the effect of the cannabinoid receptor agonist, CP 55,940, on electrically evoked transmitter release from rat brain slicesA N Gifford, L Samiian, S J Gatley, et al.
Brain Research|July 24, 1989
One year treatment with haloperidol or clozapine fails to alter neostriatal D1- and D2-dopamine receptor sensitivity in the ratC R Ashby, R Hitzemann, J E Rubinstein, et al.
Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition Et Metabolisme|March 13, 2024
Interval training and cardiometabolic health in reproductive-aged femalesT Moholdt, M A J Sujan, E R Ashby, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|October 7, 2022
Handgrip Strength Index: A Novel Parameter Which Quantifies Clinical Weakness in People on HaemodialysisTina Dilloway, Damien R Ashby, Mary Hickson, et al.
Synapse (New York, N.Y.)|January 1, 1996
The effect of the acute and chronic administration of CP 96,345, a selective neurokinin1 receptor antagonist, on midbrain dopamine neurons in the rat: a single unit, extracellular recording studyY Minabe, K Emori, A Toor, et al.
Brain Research|September 9, 1996
5-HT3-like receptors in the rat medial prefrontal cortex: further pharmacological characterizationE Edwards, E Hampton, C R Ashby, et al.
Synapse (New York, N.Y.)|September 5, 2002
Effect of SA4503 on the electrically evoked release of (3)H-acetylcholine from striatal and hippocampal rat brain slicesBryan Horan, Andrew N Gifford, Kiyoshi Matsuno, et al.
Brain Research|April 9, 1990
The effect of intraventricular administration of the 5-HT3 receptor agonist 2-methylserotonin on the release of dopamine in the nucleus accumbens: an in vivo chronocoulometric studyL H Jiang, C R Ashby, R J Kasser, et al.
Synapse (New York, N.Y.)|April 9, 2015
The selective dopamine D₃ receptor antagonist SB-277011A attenuates drug- or food-deprivation reactivation of expression of conditioned place preference for cocaine in male Sprague-Dawley ratsCharles R Ashby, Onarae V Rice, Christian A Heidbreder, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1994
The behavioral effects of the stereoisomers of 4-methylaminorex, a psychostimulant, in the ratK Batsche, C R Ashby, C Lee, et al.
Pageof 32